Rivastigmine Clinical Trials

• An Open-Label Extension to Evaluate the Efficacy and Safety of Rivastigmine Capsules in Patients with Probable Vascular Dementia
  ClinicalTrials.gov Identifier: NCT00130338 - Completed
  Vascular Dementia
  
• Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00257868 - Completed
  Delirium
  
• Efficacy and Safety of Rivastigmine Capsules in Patients with Probable Vascular Dementia
  ClinicalTrials.gov Identifier: NCT00099216 - Completed
  Vascular Dementia
  
• Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
  ClinicalTrials.gov Identifier: NCT00506415 - Recruiting
  Alzheimer Disease
  
• Safety and Tolerability of Long-Term Treatment by Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00531609 - Recruiting
  Alzheimer's Disease
  
• Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00423085 - Recruiting
  Alzheimer's Disease
  
• Clinical Effectiveness of 10 cm2 Rivastigmine Patch in Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00561392 - Recruiting
  Alzheimer's Disease
  
• Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00549601 - Recruiting
  Alzheimer's Disease
  
• Rivastigmine for Methamphetamine-Dependent Individuals - 1
  ClinicalTrials.gov Identifier: NCT00158210 - Recruiting
  
  
• Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients with Probable Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00099242 - Completed
  Alzheimer's Disease; Dementia, Alzheimer Type
  
• Efficacy and Safety of Rivastigmine in Patients with Mild Cognitive Impairment
  ClinicalTrials.gov Identifier: NCT00134953 - Terminated
  Mild Cognitive Impairment (MCI)
  
• An Open-Label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00219232 - Completed
  Alzheimer's Disease
  
• Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00305903 - Completed
  Alzheimer's Disease
  
• Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00428389 - Completed
  Alzheimer's Disease
  
• Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
  ClinicalTrials.gov Identifier: NCT00234637 - Completed
  Alzheimer's Disease
  
• Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00104442 - Completed
  Alzheimer's Disease
  
• Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment
  ClinicalTrials.gov Identifier: NCT00171795 - Completed
  Traumatic Brain Injury
  
• Neuromodulation and language acquisition (Stage Ib)
  ClinicalTrials.gov Identifier: NCT00102856 - Suspended
  Healthy
  
• Investigation into Delay to Diagnosis of Alzheimer's Disease with Exelon (InDDEx)
  ClinicalTrials.gov Identifier: NCT00000174 - Completed
  Alzheimer Disease; Cognition Disorders
  
• An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits
  ClinicalTrials.gov Identifier: NCT00219245 - Completed
  Traumatic Brain Injury With Persistent Cognitive Deficits
  
• Neuromodulation and Language Acquisition (Project stage Ia)
  ClinicalTrials.gov Identifier: NCT00102284 - Terminated
  Healthy